Therapeutic inertia
Therapeutic inertia is a term used in medicine to describe the phenomenon where healthcare providers fail to initiate or intensify therapy when indicated. This can lead to suboptimal patient outcomes, particularly in chronic diseases such as hypertension, diabetes, and hyperlipidemia.
Definition[edit]
Therapeutic inertia is defined as the failure of healthcare providers to initiate or intensify therapy when indicated. This can occur for a variety of reasons, including lack of knowledge, fear of side effects, or patient resistance. It is a significant barrier to optimal patient care and can lead to poor patient outcomes.
Causes[edit]
There are several potential causes of therapeutic inertia. These include:
- Lack of knowledge: Healthcare providers may not be aware of the latest guidelines or research on a particular disease or treatment.
- Fear of side effects: Providers may be hesitant to prescribe certain medications or treatments due to concerns about potential side effects.
- Patient resistance: Patients may be resistant to starting or intensifying treatment, particularly if they are asymptomatic or if the treatment involves lifestyle changes.
Impact[edit]
Therapeutic inertia can have a significant impact on patient outcomes. In chronic diseases such as hypertension, diabetes, and hyperlipidemia, failure to initiate or intensify treatment can lead to disease progression and complications. This can result in increased healthcare costs and decreased quality of life for patients.
Strategies to Overcome[edit]
Several strategies can be used to overcome therapeutic inertia. These include:
- Education: Providing healthcare providers with up-to-date information and guidelines can help to ensure that they are aware of the latest research and recommendations.
- Shared decision-making: Involving patients in the decision-making process can help to overcome patient resistance and improve adherence to treatment.
- Use of clinical decision support systems: These systems can provide reminders and alerts to healthcare providers, helping to ensure that treatment is initiated or intensified when indicated.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
